Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeo Kosaka

Showing results (1-10 of 326) with videos related to

Pageof 33
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Molecular targeting drug of kinase inhibitors for castration resistant prostate cancer]Takeo Kosaka, Mototsugu Oya
Surgery Today|May 25, 2005
Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancerShigeki Takashima, Takeo Kosaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 23, 2016
[Prostate cancer stem cell and drug resistance]Takeo Kosaka, Mototsugu Oya
Translational Gastroenterology and Hepatology|June 16, 2017
Laparoscopic sentinel node navigation surgery for early gastric cancerShinichi Kinami, Takeo Kosaka
Cancer Science|July 11, 2018
Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
BMC Cancer|June 13, 2019
Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case reportTakeo Kosaka, Hiroshi Hongo, Mototsugu Oya
Urology Case Reports|March 10, 2016
Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate CancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
American Journal of Clinical and Experimental Urology|October 22, 2016
A metastatic castration resistant prostate cancer patient with multiple bone metastases has durable biochemical and radiological response to docetaxel chemotherapyTatsuaki Daimon, Takeo Kosaka, Mototsugu Oya
Frontiers in Oncology|October 4, 2014
Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?Takeo Kosaka, Akira Miyajima, Mototsugu Oya
BMJ Case Reports|November 27, 2015
Continuous use of enzalutamide in a patient who developed enzalutamide-induced thrombocytopeniaAtsuko Sato, Takeo Kosaka, Mototsugu Oya
Pageof 33

Showing results (1-10 of 326) with videos related to

Sort By:
Pageof 33
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Molecular targeting drug of kinase inhibitors for castration resistant prostate cancer]Takeo Kosaka, Mototsugu Oya
Surgery Today|May 25, 2005
Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancerShigeki Takashima, Takeo Kosaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 23, 2016
[Prostate cancer stem cell and drug resistance]Takeo Kosaka, Mototsugu Oya
Translational Gastroenterology and Hepatology|June 16, 2017
Laparoscopic sentinel node navigation surgery for early gastric cancerShinichi Kinami, Takeo Kosaka
Cancer Science|July 11, 2018
Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
BMC Cancer|June 13, 2019
Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case reportTakeo Kosaka, Hiroshi Hongo, Mototsugu Oya
Urology Case Reports|March 10, 2016
Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate CancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
American Journal of Clinical and Experimental Urology|October 22, 2016
A metastatic castration resistant prostate cancer patient with multiple bone metastases has durable biochemical and radiological response to docetaxel chemotherapyTatsuaki Daimon, Takeo Kosaka, Mototsugu Oya
Frontiers in Oncology|October 4, 2014
Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?Takeo Kosaka, Akira Miyajima, Mototsugu Oya
BMJ Case Reports|November 27, 2015
Continuous use of enzalutamide in a patient who developed enzalutamide-induced thrombocytopeniaAtsuko Sato, Takeo Kosaka, Mototsugu Oya
Pageof 33